tiprankstipranks
Biosyent Inc (TSE:RX)
:RX
Canadian Market
RX
Biosyent
RESEARCH TOOLSreports

Biosyent (RX) Income Statement

53 Followers

Biosyent Income Statement

Last quarter (Q4 2025), Biosyent's total revenue was C$9.67M, an increase of 9.95% from the same quarter last year. In Q4, Biosyent's net income was C$1.99M. See Biosyent’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 43.05MC$ 35.03MC$ 31.59MC$ 27.93MC$ 28.62M
Gross Profit
C$ 32.11MC$ 27.86MC$ 25.60MC$ 22.86MC$ 22.64M
Operating Expenses
C$ 20.80MC$ 19.10MC$ 18.13MC$ 15.95MC$ 14.39M
Depreciation and Amortization
C$ 852.49KC$ 589.95KC$ 455.34KC$ 451.00KC$ 457.11K
EBITDA
C$ 12.17MC$ 10.43MC$ 9.06MC$ 7.43MC$ 8.64M
Operating Income
C$ 11.31MC$ 8.75MC$ 7.47MC$ 6.98MC$ 8.18M
Other Income/Expenses
C$ 716.86KC$ 1.03MC$ 1.06MC$ 448.65KC$ 195.22K
Pretax Income
C$ 12.03MC$ 9.78MC$ 8.53MC$ 7.43MC$ 8.38M
Net Income
C$ 9.01MC$ 7.27MC$ 6.46MC$ 5.46MC$ 6.28M
Per Share Metrics
Basic EPS
C$ 0.80C$ 0.63C$ 0.54C$ 0.44C$ 0.50
Diluted EPS
C$ 0.78C$ 0.62C$ 0.53C$ 0.44C$ 0.49
Weighted Average Shares Outstanding
 11.26M 11.59M 11.95M 12.30M 12.69M
Weighted Average Shares Outstanding (Diluted)
 11.51M 11.81M 12.17M 12.54M 12.87M
Currency in CAD

Biosyent Earnings and Revenue History